Why study technologies and analytics in precision medicine at RCSI?
The health sector faces a new era as it seeks to incorporate the areas of data science, omics, bioinformatics, computational biology and machine-learning to create a future of ‘connected healthcare’.
Disruption to existing models of healthcare delivery, along with increasing demand for healthcare access, an aging population and the associated cost challenges, have led to an increased focus on preventative medicine and tailored therapies for individual patients. The fusion of digital technology with traditional science will shape the future of healthcare, not only in Ireland but on a global scale as our world adapts.
This creates a need for a skilled and educated workforce that is focused on emerging and future healthcare technologies and can deliver through multi-disciplinary and collaborative approaches. The MSc in Technologies and Analytics in Precision Medicine at RCSI aims to equip this talent pool to address emerging skills gaps and enable future growth in the healthcare and the (bio)pharmaceutical industry.
This project has been supported by the Higher Education Authority under the Human Capital Initiative, Pillar 3. Grant agreement: 17796884 'Enabling Future Pharma’.
We have collaborated with industry partners Congenica Ltd, Novartis, Microsoft, Aerogen, S3 Connected Health, Inflection Biosciences, Phion Therapeutics and Almac in the development of the grant application that has led to this programme.